JONATHAN HSU: Open Payments
NPI 1649726514 · LEWISTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,610 in 120 payments from 19 companies in 2025. Trend: 2023 $731 · 2024 $18,794 · 2025 $2,610
Food & beverage: $2,488Education: $122
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 24 | $440 |
| AstraZeneca Pharmaceuticals LP | 13 | $326 |
| Verona Pharma, Inc. | 12 | $261 |
| Amgen Inc. | 15 | $244 |
| JAZZ PHARMACEUTICALS INC. | 7 | $217 |
| GENZYME CORPORATION | 8 | $183 |
| Regeneron Healthcare Solutions, Inc. | 8 | $151 |
| Grifols USA, LLC | 6 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $131 |
| ALK-Abello, Inc | 5 | $114 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, Ohtuvayre, XYWAV, TRELEGY ELLIPTA, BREZTRI, Prolastin-C Liquid.
Industry payments across PA — which companies pay providers there.
